{"id":"dd443b35-8f5d-54d5-99e5-9a26428a021a","stable_key":"e054f0f5-417f-5850-a874-91ff2c9de631:apt2-kd-dhhc6-stability","predicate":"has_contextual_experimental_effect","statement":"LYPLA2 silencing accelerated ZDHHC6 decay in HeLa pulse-chase experiments, shortening the reported apparent half-life from about 16 hours to about 3 hours.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"8bfc3772-0bf7-50c7-8e92-91e001303649","mechanism_event_label":"apt2 kd dhhc6 stability","subject":{"id":"1e0b32e0-ee55-5ac5-9fb8-f00aee636160","slug":"human-apt2-knockdown-hela","display_name":"Human APT2 knockdown in HeLa","entity_type_key":"protein_state"},"object":{"id":"7f04ce98-df31-5bd8-86af-6b24c34fc47f","slug":"human-zdhhc6-protein-stability","display_name":"ZDHHC6 protein stability in human cells","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"8bfc3772-0bf7-50c7-8e92-91e001303649","stable_key":"e054f0f5-417f-5850-a874-91ff2c9de631:apt2-kd-dhhc6-stability","event_type":"experimental_result","label":"apt2 kd dhhc6 stability","description":"LYPLA2 silencing accelerated ZDHHC6 decay in HeLa pulse-chase experiments, shortening the reported apparent half-life from about 16 hours to about 3 hours.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"1e0b32e0-ee55-5ac5-9fb8-f00aee636160","slug":"human-apt2-knockdown-hela","display_name":"Human APT2 knockdown in HeLa","entity_type_key":"protein_state"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"7f04ce98-df31-5bd8-86af-6b24c34fc47f","slug":"human-zdhhc6-protein-stability","display_name":"ZDHHC6 protein stability in human cells","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"f2ffef5b-5457-50a8-b787-b8f24430f610","slug":"lypla2","display_name":"LYPLA2","entity_type_key":"protein"},"role":"base protein","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"a2fd4b35-5483-5e7c-9604-d792fa67d402","slug":"zdhhc6","display_name":"ZDHHC6","entity_type_key":"protein"},"role":"measured protein","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_cache","value_text":"artifacts/discovery-research/round6-sources/zdhhc6-primary-passages.json; SHA256 a02040bb8922a9170e095cdfb5e875a5e7f513b682c0ec69c19feacb3dc191b0","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Human HeLa; LYPLA2 siRNA and tagged ZDHHC6","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"72-hour siRNA protocol; 2-hour metabolic protein pulse followed by chase. Reported apparent half-lives, not raw-data refits.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"These are separate experimental observations, not a demonstrated sulforaphane-GPX4-ZDHHC6 pathway. Sulforaphane-driven APT2 relocalization is not equivalent to genetic depletion or general catalytic inhibition. No dietary, clinical or selenium-repletion effect is inferred. Protein stability, palmitoylation and substrate output remain different measurements. C328 mutation abolished sensitivity and MG132 rescued degradation in the reported experiments. Higher regulatory palmitoylation is not equivalent to sustained higher ZDHHC6 abundance.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"organism","value_text":"Human experimental cells; construct species unresolved where stated for discussion-only nulls","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_locator","value_text":"Figure 3A-E; ZDHHC6 palmitoylation controls degradation","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"https://doi.org/10.7554/eLife.27826","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"source_access","value_text":"Selected primary Results, figure legends and methods via indexed publisher text. No supplement or raw-data reanalysis.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"19225674-4804-58d0-8c7d-ba82031429a1","evidence_kind":"source_excerpt","locator":"Lines 96-104","start_line":96,"end_line":104,"excerpt":"LYPLA2 silencing accelerated ZDHHC6 decay in HeLa pulse-chase experiments, shortening the reported apparent half-life from about 16 hours to about 3 hours.\nprimary_references: https://doi.org/10.7554/eLife.27826\nprimary_locator: Figure 3A-E; ZDHHC6 palmitoylation controls degradation\nsource_access: Selected primary Results, figure legends and methods via indexed publisher text. No supplement or raw-data reanalysis.\nevidence_cache: artifacts/discovery-research/round6-sources/zdhhc6-primary-passages.json; SHA256 a02040bb8922a9170e095cdfb5e875a5e7f513b682c0ec69c19feacb3dc191b0\nexperimental_model: Human HeLa; LYPLA2 siRNA and tagged ZDHHC6\norganism: Human experimental cells; construct species unresolved where stated for discussion-only nulls\nexposure: 72-hour siRNA protocol; 2-hour metabolic protein pulse followed by chase. Reported apparent half-lives, not raw-data refits.\nlimitations: These are separate experimental observations, not a demonstrated sulforaphane-GPX4-ZDHHC6 pathway. Sulforaphane-driven APT2 relocalization is not equivalent to genetic depletion or general catalytic inhibition. No dietary, clinical or selenium-repletion effect is inferred. Protein stability, palmitoylation and substrate output remain different measurements. C328 mutation abolished sensitivity and MG132 rescued degradation in the reported experiments. Higher regulatory palmitoylation is not equivalent to sustained higher ZDHHC6 abundance.","model_system":"Human HeLa; LYPLA2 siRNA and tagged ZDHHC6","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Curator paraphrase and primary locator; not a verbatim publisher quote. Null-result limitations retained.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"d7785cbf-e87c-5662-a76c-7ef11586cca5","stable_key":"import-e054f0f5-417f-5850-a874-91ff2c9de631","title":"APT2: sulforaphane engagement, GPX4 stability and ZDHHC6 turnover","document_type":"imported_text","citation_label":"Targeted primary-literature curation from recursive ZDHHC6 exploration, 2026-09-20.","file_path":"","sha256":"011acbeafd419a6826789806b59b5d7ff312b222762824580036325083586956","revision_id":"663a0bd1-3e46-5fee-ab0f-dcf992b2a809","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}